BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 35468369)

  • 1. Generation of a human induced pluripotent stem cell (iPSC) line (JUCTCi019-A) from a patient with Charcot-Marie-Tooth disease type 2A2 (CMT2A2) due to a heterozygous missense substitution c.2119C > T (p.Arg707Trp) in MFN2 gene.
    Ababneh NA; Barham R; Al-Kurdi B; Ali D; Hadidi SA; A Ismail M; Muamar ASH; Abdulelah AA; Madadha A; Sallam M; Hassona Y; Masri A; Awidi A
    Stem Cell Res; 2022 Jul; 62():102786. PubMed ID: 35468369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of induced pluripotent stem cell line, ZJUCHi002-A, from Charcot-Marie-Tooth disease type 2A (CMT2A) patient with a mutation of c.752C>T in MFN2.
    Xu J; Fu Y; Xia W; He J; Zou Y; Ruan W; Lou Q; Li Y; Pan J; Li H; Chen W
    Stem Cell Res; 2019 Apr; 36():101411. PubMed ID: 30807887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of a human induced pluripotent stem cell line, JUCTCi012-A, from multiple symmetric lipomatosis (MSL) patient carrying a homozygous Arg707Trp (c.2119C > T) mutation in the MFN2 gene.
    Ababneh NA; Ali D; Barham R; Al-Kurdi B; Sharar N; Al Hadidi S; Qanno' O; Ryalat AT; Salah B; Awidi A
    Stem Cell Res; 2020 Oct; 48():101967. PubMed ID: 32916636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of induced pluripotent stem cell (iPSC) line from a 36-year-old Charcot-Marie-Tooth disease patient with GJB1 mutation (CMTX).
    Son D; Kang PJ; Yun W; You S
    Stem Cell Res; 2017 May; 21():9-12. PubMed ID: 28677541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of induced pluripotent stem cell (iPSC) line from Charcot-Marie-Tooth disease patient with MPZ mutation (CMT1B).
    Son D; Kang PJ; Yun W; You S
    Stem Cell Res; 2017 Oct; 24():5-7. PubMed ID: 29034895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of a human Charcot-Marie-Tooth disease type 1B (CMT1B) iPSC line, ZJUCHi001-A, with a mutation of c.292C>T in MPZ.
    Xu J; Wang Y; He J; Xia W; Zou Y; Ruan W; Lou Q; Li Y; Li H; Chen W
    Stem Cell Res; 2019 Mar; 35():101407. PubMed ID: 30785048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Axonal Charcot-Marie-Tooth disease patient-derived motor neurons demonstrate disease-specific phenotypes including abnormal electrophysiological properties.
    Saporta MA; Dang V; Volfson D; Zou B; Xie XS; Adebola A; Liem RK; Shy M; Dimos JT
    Exp Neurol; 2015 Jan; 263():190-9. PubMed ID: 25448007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of a disease-specific iPS cell line derived from a patient with Charcot-Marie-Tooth type 2K lacking functional GDAP1 gene.
    Martí S; León M; Orellana C; Prieto J; Ponsoda X; López-García C; Vílchez JJ; Sevilla T; Torres J
    Stem Cell Res; 2017 Jan; 18():1-4. PubMed ID: 28395795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A French family with Charcot-Marie-Tooth disease related to simultaneous heterozygous MFN2 and GDAP1 mutations.
    Vital A; Latour P; Sole G; Ferrer X; Rouanet M; Tison F; Vital C; Goizet C
    Neuromuscul Disord; 2012 Aug; 22(8):735-41. PubMed ID: 22546700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined RNA interference and gene replacement therapy targeting MFN2 as proof of principle for the treatment of Charcot-Marie-Tooth type 2A.
    Rizzo F; Bono S; Ruepp MD; Salani S; Ottoboni L; Abati E; Melzi V; Cordiglieri C; Pagliarani S; De Gioia R; Anastasia A; Taiana M; Garbellini M; Lodato S; Kunderfranco P; Cazzato D; Cartelli D; Lonati C; Bresolin N; Comi G; Nizzardo M; Corti S
    Cell Mol Life Sci; 2023 Nov; 80(12):373. PubMed ID: 38007410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of a human iPSC line (MPIi008-A) from a patient with Denys-Drash syndrome.
    Doeser MC; Krygin J; Röpke A; Han D; Wedlich-Söldner R; Schöler HR; Pavenstädt H; Kim KP
    Stem Cell Res; 2022 Jul; 62():102826. PubMed ID: 35667217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of an induced pluripotent stem cell line (CSC-44) from a Parkinson's disease patient carrying a compound heterozygous mutation (c.823C>T and EX6 del) in the PARK2 gene.
    Marote A; Pomeshchik Y; Goldwurm S; Collin A; Lamas NJ; Pinto L; Salgado AJ; Roybon L
    Stem Cell Res; 2018 Mar; 27():90-94. PubMed ID: 29353703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
    Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
    Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel p.Val244Leu mutation in MFN2 leads to Charcot-Marie-Tooth disease type 2.
    Yang Y; Li L
    Ital J Pediatr; 2016 Mar; 42():28. PubMed ID: 26956144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective mitochondrial depletion, apoptosis resistance, and increased mitophagy in human Charcot-Marie-Tooth 2A motor neurons.
    Rizzo F; Ronchi D; Salani S; Nizzardo M; Fortunato F; Bordoni A; Stuppia G; Del Bo R; Piga D; Fato R; Bresolin N; Comi GP; Corti S
    Hum Mol Genet; 2016 Oct; 25(19):4266-4281. PubMed ID: 27506976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel mutation of the MFN2 gene in a Chinese family with Charcot-Marie-Tooth disease.
    Wang YW; Han WT; Jiang M; Lu CX; Li XF; Zhang X; Li JX
    Genet Mol Res; 2012 May; 11(2):1454-9. PubMed ID: 22653593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MFN2-related Charcot-Marie-Tooth Disease with Atypical Ocular Manifestations.
    Nan H; Hata T; Fukao T; Fukao T; Chen W; Kurita T; Natori T; Takiyama Y
    Intern Med; 2021 Dec; 60(24):3969-3974. PubMed ID: 34121014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation, genome edition and characterization of iPSC lines from a patient with coenzyme Q
    Romero-Moya D; Castaño J; Santos-Ocaña C; Navas P; Menendez P
    Stem Cell Res; 2017 Oct; 24():144-147. PubMed ID: 28465093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of induced pluripotent stem cell line NIMHi010-A from dermal fibroblast cells of a healthy individual.
    Dash SS; Arunachal G; Nimonkar MM; Vengalil S; Nashi S; Chetan GK; Boddu VK; Nalini A; Markandeya YS
    Stem Cell Res; 2024 Apr; 76():103355. PubMed ID: 38412659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishing a human-induced pluripotent stem cell line (SMUSHi003-A) from a patient with Charcot-Marie-Tooth disease and focal segmental glomerulosclerosis.
    Lei Q; Zhou W; Huang L; Zhang Y; Xu X; Guo X
    Stem Cell Res; 2024 Apr; 76():103357. PubMed ID: 38412658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.